Glucose News and Research

RSS

Newfoundland and Labrador have highest rate of diabetes prevalence in Canada: Report

Today, the Canadian Diabetes Association released the findings from its Newfoundland and Labrador Diabetes Cost Model, stating that Newfoundland and Labrador currently has the highest rate of diabetes prevalence in Canada, with future forecasts continuing to grow at an alarming rate.

25 Nov 2010

Neptune, Acasti completes preclinical program comparing CaPre with Lovaza

Neptune Technologies & Bioressources Inc. subsidiary, Acasti Pharma Inc., reports the completion of its preclinical program designed to compare the lipid management effects of Acasti's drug candidate CaPre versus prescription drug Lovaza.

25 Nov 2010

Best diet: High protein and low good carbs

A group of European researchers have found that eating more protein and fewer refined carbohydrates helps to stay within normal weight. The team showed that men and women who had lost at least eight percent of their body weight on a low-calorie diet were kept on a maintenance diet high in protein and low in refined carbohydrates for six months. They were least likely to regain any weight, and were also the least likely to drop out of the study.

24 Nov 2010

Testing less frequently not a good way to economize for people living with diabetes

The American economy is struggling— and people living with diabetes are feeling the brunt of the rising prices of medical supplies and doctor visit co-pays. In a recent poll by dLife.com, more than 400 people living with diabetes revealed they struggle when it comes to paying for diabetic supplies.

24 Nov 2010

Combination of caffeine and glucose can improve cognitive performance: Study

The combination of caffeine and glucose can improve the efficiency of brain activity, according to a recent study in which functional magnetic resonance imaging was used to identify the neural substrate for the combined effects of these two substances.

23 Nov 2010

DaVita announces emergency preparedness information for dialysis patients during winter season

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD) and end stage renal disease (ESRD), announced today important emergency preparedness information for dialysis patients during the upcoming winter season.

23 Nov 2010

ADA systematic review provides nutrition practice guidelines to support people with diabetes

Proper nutrition therapy is essential for the successful management of type 1 and type 2 diabetes and registered dietitians (RDs) can play a key role as part of the health care team.

23 Nov 2010

Researchers investigate ways to counteract unhealthy effects of fat

A fat yet muscular mouse is helping researchers learn whether more muscle improves the cardiovascular health of obese individuals. We are looking for ways to counteract the unhealthy effects of fat, said Dr. David Stepp, vascular biologist at the Medical College of Georgia Vascular Biology Center and co-director of MCG's Diabetes & Obesity Discovery Institute.

23 Nov 2010

HIV drugs lead to insulin resistance

The same powerful drugs that have extended the lives of countless people with HIV come with a price - insulin resistance that can lead to diabetes and cardiovascular disease.

23 Nov 2010

Dangers of excess fructose

More and more people have become aware of the dangers of excessive fructose in diet. A new review on fructose in an upcoming issue of the Journal of the American Society of Nephrology (JASN) indicates just how dangerous this simple sugar may be.

23 Nov 2010

Profil Institute expands capabilities to detect cardiac safety signals in diabetes and obesity clinical trials

Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the expansion of its capabilities for cardiac safety and cardiovascular efficacy studies in the company's early phase diabetes and obesity clinical trials.

22 Nov 2010

UH physicists study workings of PGK enzyme that may cause Alzheimer's, cancer

University of Houston physicists are using complex computer simulations to illuminate the workings of a crucial protein that, when malfunctioning, may cause Alzheimer's and cancer.

20 Nov 2010

Glutaminase inhibitor: New potential target for brain tumors

Scientists at Johns Hopkins have identified a compound that could be used to starve cancers of their sugar-based building blocks. The compound, called a glutaminase inhibitor, has been tested on laboratory cultured, sugar-hungry brain cancer cells and, the scientists say, may have the potential to be used for many types of primary brain tumors.

19 Nov 2010

Anti-cancer drug smuggled using a nanocarrier past protective blood-brain barrier into brain tumours

Scientists in Germany have developed a way of smuggling an anti-cancer drug past the protective blood-brain barrier and into brain tumours and metastases using a nanocarrier - a tiny capsule specially designed to pass through cell membranes and deliver its anti-cancer drug to the cancer cell.

18 Nov 2010

Myrexis presents data on MPC-9528 cancer metabolism inhibitor at EORTC/NCI/AACR Symposium

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented two posters at the 22nd European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR) Symposium on "Molecular Targets and Cancer Therapeutics," in Berlin, Germany.

18 Nov 2010

New cellular pathway could help develop therapeutic treatments for obesity-related disorders

Cardiac researchers at the University of Cincinnati (UC) have found a new cellular pathway that could help in developing therapeutic treatments for obesity-related disorders, like diabetes and heart disease.

17 Nov 2010

MedImmune to present data on oncology portfolio at two medical congresses in Europe and the U.S.

Today, MedImmune announced that researchers will present data from its oncology portfolio, including new clinical data, at two upcoming medical congresses in Europe and the United States.

17 Nov 2010

Shengtai 2010 first quarter sales revenue increases 49.80% to $34,644,572

Shengtai Pharmaceutical, Inc., a manufacturer and distributor in China of glucose and starch as pharmaceutical raw materials and other starch and glucose products, today reported financial results for the three months ended September 30, 2010.

17 Nov 2010

JDRF, Amylin collaborate to support metreleptin study for type 1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.

17 Nov 2010

Study confirms healthy lifestyle has the biggest impact on cardiovascular health

Two large studies from Northwestern Medicine confirm a healthy lifestyle has the biggest impact on cardiovascular health. One study shows the majority of people who adopted healthy lifestyle behaviors in young adulthood maintained a low cardiovascular risk profile in middle age.

16 Nov 2010

Glucose News and Research

Newfoundland and Labrador have highest rate of diabetes prevalence in Canada: Report

Neptune, Acasti completes preclinical program comparing CaPre with Lovaza

Best diet: High protein and low good carbs

Testing less frequently not a good way to economize for people living with diabetes

Combination of caffeine and glucose can improve cognitive performance: Study

DaVita announces emergency preparedness information for dialysis patients during winter season

ADA systematic review provides nutrition practice guidelines to support people with diabetes

Researchers investigate ways to counteract unhealthy effects of fat

HIV drugs lead to insulin resistance

Dangers of excess fructose

Profil Institute expands capabilities to detect cardiac safety signals in diabetes and obesity clinical trials

UH physicists study workings of PGK enzyme that may cause Alzheimer's, cancer

Glutaminase inhibitor: New potential target for brain tumors

Anti-cancer drug smuggled using a nanocarrier past protective blood-brain barrier into brain tumours

Myrexis presents data on MPC-9528 cancer metabolism inhibitor at EORTC/NCI/AACR Symposium

New cellular pathway could help develop therapeutic treatments for obesity-related disorders

MedImmune to present data on oncology portfolio at two medical congresses in Europe and the U.S.

Shengtai 2010 first quarter sales revenue increases 49.80% to $34,644,572

JDRF, Amylin collaborate to support metreleptin study for type 1 diabetes

Study confirms healthy lifestyle has the biggest impact on cardiovascular health

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News